24-hour provoked urine excretion test for heavy metals in children with autism and typically developing controls, a pilot study
- PMID: 17503250
- DOI: 10.1080/15563650701338195
24-hour provoked urine excretion test for heavy metals in children with autism and typically developing controls, a pilot study
Abstract
Introduction: The complementary and alternative medicine practice of prescribing chelators to children with autism is based on the premise that the chronic symptoms of autism can be ameliorated by reducing heavy metal body burden. However, there has not been definitive evidence, published to date, to support the assertion that children with autism are at increased risk of an excess chelatable body burden of heavy metals. The oral chelator meso-2,3-dimercaptosuccinic acid (DMSA) can be used diagnostically to mobilize heavy metals from extravascular pools, enhancing the identification of individuals who have a chelatable body burden.
Methods: Seventeen children with autism and five typically developing children were enrolled in a pilot study to test for chelatable body burden of Arsenic (As), Cadmium (Cd), Lead (Pb), and Mercury (Hg). Evaluation included a questionnaire regarding potential exposure to heavy metals, diet restrictions, a baseline 24-hour urine collection, and a DMSA-provoked urine collection. Urine collections were sent for As, Cd, Pb, and Hg quantification by Inductively Coupled Plasma-Mass Spectrometry. Unprovoked reference ranges were used in the interpretation of all collections.
Results: Fifteen autistic children and four typically developing children completed the study. Three autistic subjects excreted one metal in greater quantity during the provoked excretion than baseline. Two of these were very close to the limit of detection. In the third case, the provoked excretion of mercury was between the upper limit of normal and lower limit of the potentially toxic reference range. Fish was removed from this child's diet for greater than one month, and the provoked excretion test repeated. The repeat excretion of mercury was within the normal range.
Conclusion: In the absence a proven novel mode of heavy metal toxicity, the proportion of autistic participants in this study whose DMSA provoked excretion results demonstrate an excess chelatable body burden of As, Cd, Pb, or Hg is zero. The confidence interval for this proportion is 0-22%.
Comment in
-
A reply to Soden et al.: your data shows autistic children have higher levels of heavy metals.Clin Toxicol (Phila). 2008 Dec;46(10):1098; author reply 1098. doi: 10.1080/15563650802314368. Clin Toxicol (Phila). 2008. PMID: 18941966 No abstract available.
Similar articles
-
Chromium, cadmium, and lead levels in urine of children with autism and typically developing controls.Biol Trace Elem Res. 2010 Jun;135(1-3):10-5. doi: 10.1007/s12011-009-8494-7. Epub 2009 Aug 18. Biol Trace Elem Res. 2010. PMID: 19688188
-
A clinical trial of combined anti-androgen and anti-heavy metal therapy in autistic disorders.Neuro Endocrinol Lett. 2006 Dec;27(6):833-8. Neuro Endocrinol Lett. 2006. PMID: 17187010 Clinical Trial.
-
Chelated lead in relation to lead in bone and ALAD genotype.Environ Res. 1999 May;80(4):389-98. doi: 10.1006/enrs.1998.3936. Environ Res. 1999. PMID: 10330313
-
Dimercaptosuccinic acid (DMSA), a non-toxic, water-soluble treatment for heavy metal toxicity.Altern Med Rev. 1998 Jun;3(3):199-207. Altern Med Rev. 1998. PMID: 9630737 Review.
-
[Substitutive and dietetic approaches in childhood autistic disorder: interests and limits].Encephale. 2008 Oct;34(5):496-503. doi: 10.1016/j.encep.2007.10.011. Epub 2008 Mar 4. Encephale. 2008. PMID: 19068339 Review. French.
Cited by
-
Associations of Metabolic Genes (GSTT1, GSTP1, GSTM1) and Blood Mercury Concentrations Differ in Jamaican Children with and without Autism Spectrum Disorder.Int J Environ Res Public Health. 2021 Feb 3;18(4):1377. doi: 10.3390/ijerph18041377. Int J Environ Res Public Health. 2021. PMID: 33546147 Free PMC article.
-
Systematic Assessment of Research on Autism Spectrum Disorder (ASD) and Mercury Reveals Conflicts of Interest and the Need for Transparency in Autism Research.Sci Eng Ethics. 2017 Dec;23(6):1691-1718. doi: 10.1007/s11948-017-9983-2. Sci Eng Ethics. 2017. Retraction in: Sci Eng Ethics. 2017 Dec;23(6):1689-1690. doi: 10.1007/s11948-015-9713-6. PMID: 29119411 Free PMC article. Retracted. Review.
-
Advanced pharmacotherapy evidenced by pathogenesis of autism spectrum disorder.Clin Psychopharmacol Neurosci. 2014 Apr;12(1):19-30. doi: 10.9758/cpn.2014.12.1.19. Epub 2014 Apr 24. Clin Psychopharmacol Neurosci. 2014. PMID: 24851117 Free PMC article. Review.
-
Interaction between manganese and GSTP1 in relation to autism spectrum disorder while controlling for exposure to mixture of lead, mercury, arsenic, and cadmium.Res Autism Spectr Disord. 2018 Nov;55:50-63. doi: 10.1016/j.rasd.2018.08.003. Epub 2018 Sep 5. Res Autism Spectr Disord. 2018. PMID: 30930959 Free PMC article.
-
Environmental toxicants and autism spectrum disorders: a systematic review.Transl Psychiatry. 2014 Feb 11;4(2):e360. doi: 10.1038/tp.2014.4. Transl Psychiatry. 2014. PMID: 24518398 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials